Interactions between gut microbiome and gut protein receptors: Implications for genomic studies and health outcomes

The gut microbiome, comprising a wide range of bacteria, viruses, and fungi, plays a vital role in maintaining human health. Its composition is influenced by factors such as diet, environment, and genetics, which in turn affect the microbiomes functions in digestion, immune regulation, and metabolism. The core of these functions is the production of metabolites and signalling molecules that interact with protein receptors in the gut. These receptors, including G-protein-coupled receptors (GPCRs) and toll-like receptors (TLRs), regulate gut physiology, such as motility, secretion, and barrier integrity. The interactions between gut microbial metabolites, such as short-chain fatty acids and bile acids, and these receptors are crucial in modulating immune responses, nutrient absorption, and host metabolism. Understanding these complex interactions is essential for advancing genomic studies, as they reveal critical gene-environment interactions and epigenetic modifications mediated by the gut microbiota. By integrating microbiome and genomic data, we can explore microbiome-receptor interactions through genome-wide association studies and multi-omics approaches, making the way for personalized medicine. These insights have profound implications for health outcomes, particularly in chronic diseases like obesity, diabetes, and inflammatory bowel disease (IBD), as well as mental health disorders. Therapeutic interventions, including probiotics, prebiotics, and receptor-targeting drugs, hold promise for modulating these interactions. Future research directions focus on translating these findings into clinical practice, offering potential for targeted therapies and personalized interventions that improve health outcomes.